Retinitis pigmentosa: Understanding the clinical presentation, mechanisms and treatment options

Clinical and Experimental Optometry

Volumn 87, Issue 2, 2004, Pages 65-80

  Kalloniatis, Michael ^a   Fletcher, Erica L ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cgmp; Degeneration; Gene mutations; Retina; Retinal transplants; Retinitis pigmentosa; Visual field; Vitamin A

Indexed keywords

ADULT; CASE REPORT; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PEDIGREE; PRACTICE GUIDELINE; RETINITIS PIGMENTOSA; REVIEW; VISUAL FIELD;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PRACTICE GUIDELINES; RETINITIS PIGMENTOSA; VISUAL FIELDS;

EID: 2942685882     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.2004.tb03152.x     Document Type: Review

References (152)

1. Haim M. Epidemiology of retinitis pigmentosa in Denmark. Acta Ophthalmol Scand Suppl 2002;233:1-34.
2. Cibis GW, Abdel-Latif AA, Bron AJ, Chalam KV, Tripathi BJ, Tripathi RC, Wiggs J, Aaby AA. Basic and Clinical Science Course-Section 2: Fundamental and Principles of Ophthalmology. The foundation of the American Academy of Ophthalmology. 2001. p355-386.
3. Bessant DAR, Kaushal S, Bhattacharya SS. Genetics and biology of the inherited retinal dystrophies. In: Kaufman PL, Alm A, eds. Adler's Physiology of the Eye, 10th ed. St Louis: Mosby; 2003. p358-381.
4. Pacione LR, Szego MJ, Ikeda S, Nishina PM, McInnes RR. Progress toward understanding the genetic and biochemical mechanisms of inherited photoreceptor degenerations. Annu Rev Neurosci 2003;26:657-700.
5. Dowling JE. The Retina: An Approachable Part of the Brain. Cambridge MA: The Belknap Press; 1987.
6. Wu SM, Maple BR. Amino acid neurotransmitters in the retina: a functional overview. Vision Res 1998;38:1371-1384.
7. Werblin FS, Dowling JE. Organization of the retina of the mudpuppy, Necturus maculosus. II. Intracellular recording. J Neurophys 1969;32:339-355.
8. Kaneko A. Receptive field organization of bipolar and amacrine cells in the goldfish retina. J Physiol (Lond) 1973; 235, 133-153.
9. Stell WK, Lightfoot DO, Wheeler TG, Leeper HF. Goldfish retina: functional polarization of cone horizontal cell dendrites and synapses. Science 1975;190:989-990.
10. Naka KI. The cells horizontal cells talk to. Vision Res 1982;22:653-660.
11. Sakuranaga M, Naka K. Signal transmission in the catfish retina. I. Transmission in the outer retina. J Neurophysiol 1985;53:373-389. (Pubitemid 15134953)
12. Ripps H, Witkovsky P. Neuroglia interaction in the brain and retina. Prog Retinal Res 1985;4:181-219.
13. La Cour M. The retinal pigment epithelium. In: Kaufman PL, Alm A, eds. Adler's Physiology of the Eye, 10th ed. St Louis: Mosby; 2003. p 348-357.
14. Mata NL, Radu RA, Clemmons RC, Travis GH. Isomerization and oxidation of vitamin A in cone-dominant retinas: a novel pathway for visual-pigment regeneration in daylight. Neuron 2002;36:69-80.
15. Bunt-Milam AH, Saari JC. Immunocytochemical localization of two retinoidbinding proteins in vertebrate retina. J Cell Biol 1983;97:703-712.
16. Bok D, Ong DE, Chytil F. Immunocytochemical localization of cellular retinol binding protein in the rat retina. Invest Ophthalmol Vis Sci 1984;25:877-883.
17. Jones GJ, Crouch RK, Wiggert B, Cornwall MC, Chader GJ. Retinoid requirements for recovery of sensitivity after visual-pigment bleaching in isolated photoreceptors. Proc Natl Acad Sci USA 1989;86:9606-9610.
18. Fesenko EE, Kolesnikov SS, Lyubarsky AL. Induction by cyclic GMP of cationic conductance in plasma membrane of retinal rod outer segment. Nature 1985;313:310-313.
19. Picaud S. Retinal biochemistry. In: Kaufman PL, Alm A, eds. Adler's Physiology of the Eye, 10th ed. St Louis: Mosby; 2003. p382-408.
20. Stryer L. Visual excitation and recovery. J Biol Chem 1991;266:10711-10714.
21. McBee JK, Palczewski K, Baehr W, Pepperberg DR. Confronting complexity: the interlink of phototransduction and retinoid metabolism in the vertebrate retina. Prog Retinal Eye Res 2001;20:469-529.
22. Baehr W, Liebman P. Visual cascade. In: Nature-Encyclopedia of Life Sciences. London: Macmillan Reference Ltd; 2001. p1-8. Available from: URL: http://www.els.net.
23. Van Soest S, Westerveld A, de Jong PTVM, Bleeker-Wagemakers E, Bergen AAB. Retinitis pigmentosa: defined from a molecular point of view. Surv Ophthalmol 1999;43:321-334.
24. Phelan JK, Bok D. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Mol Vis 2000;6:116-124. Available from: URL: www.molvis.org/molvis/.
25. Baehr W, Frederick JM. Inherited retinal diseases: vertebrate animal models. In: Nature-Encyclopedia of Life Sciences. London: Macmillan Reference Ltd; 2001. p1-9. Available from: URL: http://www.els.net.
26. Koenig R. Bardet-Biedl syndrome and Usher syndrome. Dev Ophthalmol 2003;37:126-140.
27. Daiger SP, Rossiter BJF, Greenberg J, Christoffels A, Hide W. Data services and software for identifying genes and mutations causing retinal degeneration. Invest Ophthalmol Vis Sci 411998; 39: S295. Available from: URL: (http://www.sph.uth.tmc.edu/Retnet/).
28. Stone J, Maslim J, Valter-Kocsi K, Mervin K, Bowers F, Chu Y, Barnett N, Provis J, Lewis G, Fisher SK, Bisti S, Gargini C, Cervetto L, Merin S, Pe'er J. Mechanisms of photoreceptor death and survival in mammalian retina. Prog Ret Eye Res 1999;18:689-735.
29. Marmor MF, Aguirre G, Arden G, Berson E, Birch DG, Boughman JA, Carr R, Chatrianb GE, Del Monte M, Dowling J, Enoch J, Fishman GA, Fulton AB, Garcia CA, Gouras P, Heckenlively J, Hu D, Lewis RA, Niemeyer G, Parker JA, Perlman I, Ripps H, Sandberg MA, Siegel I, Weleber RG, Wolf ML, Wu L, Young RSL. Retinitis pigmentosa. Ophthalmology 1983;90:126-131.
30. Pagon RA. Retinitis pigmentosa. Surv Ophthalmol 1988;33:137-177.
31. Kanski JJ. Clinical Ophthalmology. Edinburgh: Butterworth Heinemann: 2003. p491-496.
32. Birch J. Diagnosis of Defective Colour Vision. Oxford: Butterworth Heinemann; 1993. p156-157.
33. Sandberg MA, Berson EL. Blue and green cone mechanisms in retinitis pigmentosa. Invest Ophthalmol Vis Sci 1977;16:149-157.
34. Massof RW, Finkelstein D, Starr SJ, Kenyon KR, Fleischman JA, Maumenee IH. Bilateral symmetry of vision disorders in typical retinitis pigmentosa. Br J Ophthalmol 1979;63:90-96.
35. Massof RW, Dagnelie G, Benzschawel T, Palmer RW, Finkelstein D. First order dynamics of visual field loss in retinitis pigmentosa. Clin Vision Sci 1990;5:1-26. (Pubitemid 20075821)
36. Heckenlively JR, Boughman JA, Friedman LH. Pedigree Analysis. In: Heckenlively JR. Retinitis Pigmentosa. Philadelphia, PA: Lippincott; 1988. p6-24.
37. Jay M. On the heredity of retinitis pigmentosa. Br J Ophthalmol 1982;66:405-416.
38. Boughman JA, Fishman GA. A genetic analysis of retinitis pigmentosa. Br J Ophthalmol 1983;67:449-454.
39. Fishman GA. Genetic percentages. Arch Ophthalmol 1978;96:822-826.
40. Boughman JA, Conneally PM, Nance WE. Population genetic studies of retinitis pigmentosa. Am J Hum Genet 1980;32:223-235.
41. Badano JL, Katsanis N. Beyond Mendel: an evolving view of human genetic disease transmission. Nat Rev Genet 2002;3:779-789.
42. Stone J, Malsim J, Fawsi A, Lancaster P, Heckenlively J. The role of perinatal stress in retinitis pigmentosa: evidence from surveys in Australia and the USA. Can J Ophthalmol 2001;36:15-322.
43. Kajiwara K, Berson EL, Dryja TP. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science 1994;264:1604-1608.
44. Jacobson SG, Cideciyan AV, Kemp CM, Sheffield VC, Stone EM. Photoreceptor function in heterozygotes with insertion or deletion mutations in the RDS gene. Invest Ophthalmol Vis Sci 1996;37:1662-1674.
45. Wang MX, Sando RS Jr, Crandall AS, Donoso LA. Recent advances in the molecular genetics of retinitis pigmentosa. Curr Opin Ophthalmol 1995;6:1-7.
46. Reese BE, Harvey AR, Tan SS. Radial and tangential dispersion patterns in the mouse retina are cell-class specific. Proc Natl Acad Sci USA 1995;92:2494-2498.
47. Tan SS, Godinho L, Tam PP. Cell lineage analysis. X-inactivation mosaics. Methods Mol Biol 2000;135:289-295.
48. Bird AC. Management of retinitis pigmentosa-summary. Trans Ophthalmol Soc UK 1983;103:494-495.
49. Fishman GA, Weinberg AB, McMahon TT. X-linked recessive retinitis pigmentosa: clinical characteristics of carriers. Arch Ophthalmol 1986;104:1329-1335.
50. Koenekoop RK, Loyer M, Hand CK, Al Mahdi H, Dembinska O, Beneish R, Racine J, Rouleau GA. Novel RPGR mutations with distinct retinitis pigmentosa phenotypes in French-Canadian families. Am J Ophthalmol 2003;136:678-687.
51. Tanino T, Ohba N, Mishima S. Studies on pigmentary retinal dystrophy. III. A statistical analysis of perimetric data. Klin Montsbl Augenheilkd 1977;170:808-813.
52. Pearlman JK. Mathematical models of retinitis pigmentosa: study of the rate of progress in different genetic forms. Trans Amer Ophthalmol Soc 1979;77:643-656.
53. Berson EL, Sandberg MA, Rosner B, Birch DG, Hanson AH. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol 1985;99:240-251.
54. Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Dryja TP. Ocular findings in patients with autosomal dominant retinitis pigmentosa and rhodopsin, proline-347-leucine. Am J Ophthalmol 1991;111:614-623.
55. Berson EL, Rosner B, Sandberg MA, Dryja T P. Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His). Arch Ophthalmol 1991;109:92-101.
56. Oh KT, Longmuir R, Oh DM, Stone EM, Kopp K, Brown J, Fishman GA, Sonkin P, Gehrs KM, Weleber RG. Comparison of the clinical expression of retinitis pigmentosa associated with rhodopsin mutations at codon 347 and codon 23. Am J Ophthalmol 2003;136:306-313.
57. Lewin AS, Drenser KA, Hauswirth WW, Nishikawa S, Yasumura D, Flannery JG, LaVail MM. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat Med 1998;4:967-971.
58. Olsson JE, Gordon JW, Pawlyk BS, Roof D, Hayes A, Molday RS, Mukai S, Cowley GS, Berson EL, Dryja TP. Transgenic mice with a rhodopsin mutation (Pro23His) : a mouse model of autosomal dominant retinitis pigmentosa. Neuron 1992;9:815-830.
59. Kijas JW, Cideciyan AV, Aleman TS, Pianta MJ, Pearce-Kelling SE, Miller BJ, Jacobson SG, Aguirre GD, Acland GM. Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa. Proc Natl Acad Sci USA 2002;99:6328-6333.
60. Illing ME, Rajan RS, Bence NF, Kopito RR. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J Biol Chem 2002;277:34150-34160.
61. Sanyal S, Zeilmaker GH. Development and degeneration of retina in rds mutant mice: light and electron microscopic observations in experimental chimaeras. Exp Eye Res 1984;39:231-246.
62. Birch DG, Hood DC, Nusinowitz S, Pepperberg DR. Abnormal activation and inactivation mechanisms of rod transduction in patients with autosomal dominant retinitis pigmentosa and the pro-23-his mutation. Invest Ophthalmol Vis Sci 1995;36:1603-1614.
63. Kemp CM, Jacobson SG, Roman AJ, Sung CH, Nathans J. Abnormal rod dark adaptation in autosomal dominant retinitis pigmentosa with proline-23-histidine rhodopsin mutation. Am J Ophthalmol 1992;113:165-174.
64. Jin S, Cornwall MC, Oprian DD. Opsin activation as a cause of congenital night blindness. Nat Neurosci 2003;6:731-735.
65. Lolley RN, Farber DB, Rayborn ME, Hollyfield JG. Cyclic GMP accumulation causes degeneration of photoreceptor cells: simulation of an inherited disease. Science 1977;196:664-666.
66. Farber DB, Shuster TA. Cyclic nucleotides in retinal function and degeneration. In: Adler R, Farber D, eds. The Retina: a Model for Cell Biology Studes. Part I. Florida: Academic Press; 1986. p239-296.
67. Chader GJ. Studies of animal models or retinal degeneration. In: Tso MDM. Retinal Diseases. Philadelphia: JB Lippincott; 1988. p80-89.
68. Farber DB, Flannery JG, Bowes-Rickman C. The rd mouse story: seventy years of research on an animal model of inherited retinal degeneration. Prog Retinal Eye Res 1994;13:31-63.
69. McLaughlin ME, Ehrhart TL, Berson EL, Dryja TP. Mutation spectrum of the gene encoding the beta subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa. Proc Natl Acad Sci USA 1995;92:3249-3253.
70. Ulshafer RJ, Fliesler SJ, Hollyfield JG. Differential sensitivity to protein synthesis in human retina to a phosphodiesterase inhibitor and cyclic nucleotides. Curr Eye Res 1984;3:383-392.
71. Ulshafer RJ, Garcia CA, Hollyfield JG. Sensitivity of photoreceptors to elevated levels of cGMP in the human retina. Invest Ophthalmol Vis Sci 1980; 19:1236-1241.
72. Farber DB Souza DW, Chase DG. Cone visual cell degeneration in ground squirrel retina: disruption of morphology and cyclic nucleotide metabolism by iodoacetic acid. Invest Ophthalmol Vis Sci 1983;24:1236-1249.
73. + transport. J Neurosci 1992;12:840-853.
74. Steinberg RH. Monitoring communications between photoreceptors and pigment epithelial cells: effects of 'mild' systemic hypoxia. Invest Ophthalmol Vis Sci 1987;28:1888-1904.
75. Seeliger MW, Biesalski HK, Wissinger B, Gollnick H, Gielen S, Frank J, Beck S, Zrenner E. Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein synthesis. Invest Ophthalmol Vis Sci 1999;40:3-11.
76. Bok D, Hall MO. The role of the pigment epithelium in the etiology of inherited retinal dystrophy in the rat. J Cell Biol 1971;49:664-682.
77. Mullen RJ, LaVail MM. Inherited retinal dystrophy: primary defect in pigment epithelium determined with experimental rat chimeras. Science 1976;192:799-801.
78. Tso MO, Zhang C, Abler AS, Chang CJ, Wong F, Chang GQ, Lam TT. Apoptosis leads to photoreceptor degeneration in inherited retinal dystrophy of RCS rats. Invest Ophthalmol Vis Sci 1994;35:2693-2699.
79. Fletcher EL, Kalloniatis M. Neurochemical architecture of the normal and degenerating rat retina. J Comp Neurol 1996;376:343-360. (Pubitemid 26419112)
80. Strauss O, Stumpff F, Mergler S, Weinrich M, Wiederholt M. The Royal College of Surgeons rat: An animal model for inherited retinal degeneration with a still unknown genetic defect. Acta Anatomica (Basel) 1999;162:101-111.
81. D'Cruz PM, Yasumura D, Weir J, Matthes MT, Abderrahim H, LaVail MM, Vollrath D. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Gen 2000;9:645-651.
82. Gal A, Li Y, Thompson DA, Weir J, Orth U, Jacobson SG, Apfelstedt-Sylla E, Vollrath D. Mutations in Mertk, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nature Gen 2000;26:270-271.
83. Huang PC, Gaitan AE, Hao Y, Petters RM, Wong F. Cellular interactions implicated in the mechanism of photoreceptor degeneration in transgenic mice expressing a mutant rhodopsin gene. Proc Natl Acad Sci USA 1993;90:8484-8488.
84. Massof RW, Finkelstein D. Rod sensitivity relative to cone sensitivity in retinitis pigmentosa. Invest Ophthalmol Vis Sci 1979;18:263-272.
85. Lolley RN. The rd gene defect triggers programmed rod cell death. The Proctor Lecture. Invest Ophthalmol Vis Sci 1994;35:4182-4191.
86. Rich KA, Figueroa SL, Zhan Y, Blanks JC. Effects of Muller cell disruption on mouse photoreceptor cell development. Exp Eye Res 1995;61:235-248.
87. Pow DV, Crook DK. Direct immunocytochemical evidence for the transfer of glutamine from glial cells to neurons: use of specific antibodies directed against the d-stereoisomers of glutamate and glutamine. Neurosci 1995;70:295-302.
88. Kalloniatis M, Tomisich G. Amino acid neurochemistry of the vertebrate retina. Prog Retinal Eye Res 1999;18:811-866.
89. Poitry-Yamate CL, Poitry S, Tsacopoulos M. Lactate released by Müller glial cells is metabolized by photoreceptors from mammalian retina. J Neurosci 1995;15:5179-5191.
90. Tsacopoulos M, Poitry-Yamate CL, MacLeish PR, Poitry S. Trafficking of molecules and metabolic signals in the retina. Prog Retin Eye Res 1998;17:429-442
91. Winkler BS. Glycolytic and oxidative metabolism in relation to retinal function. J Gen Physiol 1981;77:667-692.
92. Winkler BS, Arnold MJ, Brassell MA, Puro DG. Energy metabolism in human retinal Müller cells. Invest Ophthalmol Vis Sci 2000;41:3183-3190.
93. Brotherton J. Studies on the metabolism of the rat retina with special reference to retinitis pigmentosa. I. Anaerobic glycolysis. Exp Eye Res 1962;1:234-245.
94. Alder VA, Cringle SJ, Constable IJ. The retinal oxygen profile of cats. Invest Ophthalmol Vis Sci 1983;24:30-36.
95. Bui BV, Kalloniatis M, Vingrys AJ. The contribution of glycolytic and oxidative pathways to retinal photoreceptor function. Invest Ophthalmol Vis Sci 2003;44:2708-2715.
96. Kuwabara T, Cogan DG. Retinal glycogen. Arch Ophthalmol 1961;66:96-104.
97. Tsacopoulos M, Magistretti PJ. Metabolic coupling between glia and neurons. J Neurosci 1996;16:877-885.
98. Bui BV, Kalloniatis M, Vingrys AJ. Retinal function loss after monocarboxylate transport inhibition. Invest Ophthalmol Vis Sci 2004: 45: 584-593.
99. Graymore C. Possible significance of the isoenzymes of lactic dehydrogenase in the retina of the rat. Nature 1964;201:615-616.
100. Fletcher EL, Kalloniatis M. Localization of amino acid neurotransmitters during postnatal development of the rat retina. J Comp Neurol 1997;380:449-471.
101. Fletcher EL, Kalloniatis M. Neurochemical development of the degenerating rat retina. J Comp Neurol 1997;388:1-22.
102. Bonavita V, Ponte F, Amore G. Neurochemical studies on the inherited retinal degeneration of the rat. Vision Res 1963;3:271-280.
103. Reading HW, Sorsby A. The metabolism of the dystrophic retina. I: Comparative studies on the glucose metabolism of the developing rat retina, normal and dystrophic. Vision Res 1962;2:315-325.
104. Stramm LE, Pautler EL. Glucose uptake by normal and dystrophic rat retinas and ciliary bodies. Exp Eye Res 1980;30:709-718.
105. Di Mattio J, Zadunaisky JA. Reduced ocular glucose transport and increased nonelectrolyte permeability in rats with retinal degeneration (RCS). Exp Eye Res 1983;37:217-223.
106. Kalloniatis M, Tomisich G, Wellard JW, Foster LE Mapping photoreceptor and post-receptoral labelling patterns using a channel permeable probe (agmatine) during development in the normal and RCS rat retina. Visual Neurosci 2002;19:61-70.
107. Noell WK. Aspects of experimental and hereditary retinal degneration. In: Graymore C. Biochemistry of the Retina. London: Academic Press; 1965. p51-72.
108. Lolley RN. Changes in glucose and energy metabolism in vivo in developing retinae from visually-competent (DBA/1J) and mutant (C3H/HeJ) mice. J Neurochem 1972;19:175-185.
109. Lolley RN, Racz E. Changes in levels of ATPase activity in developing retinae of normal (DBA) and mutant (C3H) mice. Vision Res 1972;12:567-571.
110. Portera-Cailliau C, Sung CH, Nathans J, Adler R. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA 1994;91:974-978.
111. Goldstein SM, Syed NA, Milam AH, Maguire AM, Lawton TJ, Nichols CW. Cancer-associated retinopathy. Arch Ophthalmol 1999;117:1641-1645.
112. Ohguro H, Ogawa K, Maeda T, Maruyama I, Maeda A, Takano Y, Nakazawa M. Retinal dysfunction in cancer-associated retinopathy is improved by Ca (2+) antagonist administration and dark adaptation. Invest Ophthalmol Vis Sci 2001;42:2589-2595.
113. Maeda A, Maeda T, Ohguro H, Palczewski K, Sato N. Vaccination with recoverin, a cancer-associated retinopathy antigen, induces autoimmune retinal dysfunction and tumor cell regression in mice. Eur J Immunol 2002;32:2300-2307.
114. Keltner JL, Thirkill CE, Yip PT. Clinical and immunologic characteristics of melanomaassociated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol 2001;21:173-187.
115. Lei B, Bush RA, Milam AH, Sieving PA. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 2000;41:262-266.
116. Sharma RK, Ehinger B. Management of hereditary retinal degeneration: present status and future directions. Surv Ophthalmol 1999;43:427-444.
117. Heckenlively JR, Fawzi AA, Oversier J, Jordan, BL, Aptsiauri N. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration. Arch Ophthalmol 2000;118:1525-1533.
118. Wang T, Steel G, Milam AH, Valle D. Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina. Proc Natl Acad Sci USA 2000;97:1224-1229
119. Lund RD, Kwan AS, Keegan DJ, Sauve Y, Coffey PJ, Lawrence JM. Cell transplantation as a treatment for retinal disease. Prog Retin Eye Res 2001;20:415-449.
120. Maslim J, Valter K, Egensperger R, Hollander H, Stone J. Tissue oxygen during a critical developmental period controls the death and survival of photoreceptors. Invest Ophthalmol Vis Sci 1997;38:1667-1677.
121. Valter K, Maslim J, Bowers F, Stone J. Photoreceptor dystrophy in the RCS rat: roles of oxygen, debris and bFGF. Invest Ophthalmol Vis Sci 1998;39:2427-2442.
122. Li LX, Turner JE. Inherited retinal dystrophy in the RCS rat: prevention of photoreceptor degeneration by pigment epithelial cell transplantation. Exp Eye Res 1988;47:911-917.
123. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 1990;347:83-86.
124. Katai N, Kikuchi T, Shibuki H, Kuroiwa S, Arai J, Kurokawa T, Yoshimura N. Caspaselike proteases activated in apoptotic photoreceptors of Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 1999;40:1802-1807.
125. Organisciak DT, Darrow RM, Barsalou L, Kutty RK, Wiggert B. Susceptibility to retinal light damage in transgenic rats with rhodopsin mutations. Invest Ophthalmol Vis Sci 2003;44:486-492.
126. Frasson M, Sahel JA, Fabre M, Simonutti M, Dreyfus H, Picaud S. Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nat Med 1999; 5:1183-1187.
127. Taylor WR, Morgans C. Localization and properties of voltage-gated calcium channels in cone photoreceptors of Tupaia belangeri. Visual Neurosci 1998;15:541-552.
128. Hart J, Wilkinson MF, Kelly MEM, Barnes S. Inhibitory action of diltiazem on voltagegated calcium channels in cone photoreceptors. Exp Eye Res 2003;76:597-604.
129. Edward DP, Edward DP, Lam TT, Shahinfar S, Li J, Tso MO. Ameliaration of light-induced retinal degeneration by a calcium overload blocker. Arch Ophthalmol 1991;109:554-562.
130. Pawlyk BS, Li T, Scimeca MS, Sandberg MA, Berson EL. Absence of photoreceptor rescue with D-cis-diltiazem in the rd mouse. Invest Ophthalmol Vis Sci 2002;43:1912-1915.
131. Bush RA, Kononen L, Machida S, Sieving PA. The effect of calcium channel blocker diltiazem on photoreceptor degeneration in the rhodopsin Pro23His rat. Invest Ophthalmol Vis Sci 2000;41:2697-2701.
132. Pearce-Kelling SE, Aleman TS, Nickle A, Laties AM, Aguirre GD, Jacobson SG, Acland GM. Calcium channel blocker D-cis-diltiazem does not slow retinal degeneration in the PDE6B mutant rcd1 canine model of retinitis pigmentosa Mol Vision 2001;7:42-47.
133. Reichel MB, Ali RR, Hunt DM, Bhattacharya SS. Gene therapy for retinal degeneration. Ophthalmic Res 1997;29:261-268.
134. Lem J, Flannery JG, Li T, Applebury ML, Farber DB, Simon MI. Retinal degeneration is rescued in transgenic rd mice by expression of the cGMP phosphodiesterase beta subunit. Proc Natl Acad Sci USA 1992;89:4422-4426.
135. Travis GH, Groshan KR, Lloyd M, Bok D. Complete rescue of photoreceptor dysplasia and degeneration in transgenic retinal degeneration slow (rds) mice. Neuron 1992;9:113-119.
136. Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kelling SE, Ananad V, Zeng Y, Maguire AM, Jacobson SG, Hauswirth WW, Bennett J. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 2001;28:92-95.
137. LaVail MM, Yasumura D, Matthes MT, Lau-Villacorta C, Unoki K, Sung CH, Steinberg RH. Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci 1998;39:592-602.
138. Marc RE, Jones BW, Watt CB, Strettoi E. Neural remodeling in retinal degeneration. Prog Retin Eye Res 2003;22:607-655.
139. Jones BW, Watt CB, Frederick JM, Baehr W, Chen CK, Levine EM, Milam AH, Lavail MM, Marc RE. Retinal remodeling triggered by photoreceptor degenerations. J Comp Neurol 2003;464:1-16.
140. Weleber RG. The Cuban experience: false hope for a cure for retinitis pigmentosa. Arch Ophthalmol 1996;114:606-607.
141. Berson EL, Remulla JF, Rosner B, Sandberg MA, Weigel-DiFranco C. Evaluation of patients with retinitis pigmentosa receiving electric stimulation, ozonated blood and ocular surgery in Cuba. Arch Ophthalmol 1996;114:560-563.
142. Vingolo EM, Pelaia P, Forte R, Rocco M, Giusti C, Rispoli E. Does hyperbaric oxygen (HBO) delivery rescue retinal photoreceptors in retinitis pigmentosa? Doc Ophthalmol 1998;97:33-39.
143. Humayun MS, de Juan E Jr. Artificial vision. Eye 1998;12:605-607.
144. Humayun MS, Weiland JD, Fujii GY, Greenberg R, Williamson R, Little J, Mech B, Cimmarusti V, Van Boemel G, Dagnelie G, de Juan E. Visual perception in a blind subject with a chronic microelectronic retinal prosthesis. Vision Res 2003;43:2573-2581.
145. Rizzo JF 3rd, Wyatt J, Loewenstein J, Kelly S, Shire D. Methods and perceptual thresholds for short-term electrical stimulation of human retina with microelectrode arrays. Invest Ophthalmol Vis Sci 2003;44:5355-5361. (Pubitemid 37475410)
146. Rizzo JF 3rd, Wyatt J, Loewenstein J, Kelly S, Shire D. Perceptual efficacy of electrical stimulation of human retina with a microelectrode array during short-term surgical trials. Invest Ophthalmol Vis Sci 2003;44:5362-5369. (Pubitemid 37475411)
147. Chow AY, Chow VY. Subretinal electrical stimulation of the rabbit retina. Neurosci Lett 1997;225:13-16.
148. Zrenner E, Miliczek KD, Gabel VP, Graf HG, Guenther E, Haemmerle H, Hoefflinger B, Kohler K, Nisch W, Schubert M, Stett A, Weiss S. The development of subretinal microphotodiodes for replacement of degenerated photoreceptors. Ophthalmic Res 1997;29:269-280.
149. Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, Willett W. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993;111:761-772. (Pubitemid 23170587)
150. Oyesiku JO, Turner CF. Reproductive choices for couples with haemophilia. Haemophilia 2002;8:348-352.
151. V Chan J, TK Chan J. Prenatal diagnosis of common single gene disorders by DNA technology. Hong Kong Med J 1997;3:173-178
152. Sibulesky L, Hayes KC, Pronczuk A, Weigel-DiFranco C, Rosner B, Berson EL. Safety of < 7500 RE (< 25000 IU) vitamin A daily in adults with retinitis pigmentosa. Am J Clin Nutr 1999;69:656-663. Author's address: